Novel Approach To Treating Rett Syndrome Under Development

A paper published online in Nature Neuroscience reveals the presence of methyl CpG binding protein 2 in glia. MeCP2 is a protein associated with a variety of neurological disorders, including Rett Syndrome, the most physically disabling of the autism spectrum disorders. The researchers show that MeCP2-deficient astrocytes, a subset of glia, stunt the growth of neighboring neurons

The rest is here: 
Novel Approach To Treating Rett Syndrome Under Development

This entry was posted in Autism Resources 3 and tagged , , , , , , , , , , , , . Bookmark the permalink. Both comments and trackbacks are currently closed.